Nurse Practitioner · Stanford, CA
NPI
1134356280
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
106 services
Medicare patients, 2024
73
Average age 61
Drug cost, 2024
$3.8M
1,601 prescriptions
Company payments, 2025
$26K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jong-Mi Lee was code 99215 (office e&m - established), 41 times for 36 patients. In total Jong-Mi Lee billed 106 services in 8 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 41 | 36 | $122.67 | $5,030 |
| 99214 Office E&M - Established | Office | 31 | 25 | $91.20 | $2,827 |
| 99215 Office E&M - Established | Facility | 20 | 16 | $93.27 | $1,865 |
By year: 2022 $6,209 for 76 services; 2023 $5,638 for 74 services; 2024 $11K for 106 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jong-Mi Lee prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 174 prescriptions and refills. In total Jong-Mi Lee wrote 1,601 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 174 | 211 | 26 | $55K |
| Gabapentin Generic | 125 | 200 | 30 | $3,400 |
| Baclofen Generic | 116 | 234 | 36 | $5,228 |
| Kesimpta Pen Ofatumumab | 98 | 98 | 12 | $893K |
| Duloxetine Hcl Generic | 84 | 164 | 19 | $1,297 |
| Vumerity Diroximel Fumarate | 74 | 80 | Under 11 | $665K |
| Copaxone Glatiramer Acetate | 68 | 68 | Under 11 | $373K |
| Teriflunomide Generic | 58 | 58 | Under 11 | $6,386 |
| Tecfidera Dimethyl Fumarate | 58 | 58 | Under 11 | $525K |
| Dimethyl Fumarate Generic | 40 | 48 | Under 11 | $7,389 |
| Modafinil Generic | 38 | 44 | Under 11 | $2,040 |
| Paroxetine Hcl Generic | 38 | 50 | Under 11 | $424 |
| Mayzent Siponimod | 37 | 37 | Under 11 | $339K |
| Carbamazepine Er Carbamazepine | 32 | 50 | Under 11 | $3,160 |
| Plegridy Pen Peginterferon Beta-1a | 31 | 31 | Under 11 | $234K |
Brand drugs: 445 claims; generic drugs: 1,156 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jong-Mi Lee $26K ($26K in general payments such as food, travel and fees) from 7 companies. The largest payer was Genzyme Corporation with $6,475.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.